NCT00101244 2013-01-14SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 1 Terminated31 enrolled